vs

Side-by-side financial comparison of IQVIA (IQV) and Kimberly-Clark (KMB). Click either name above to swap in a different company.

Kimberly-Clark is the larger business by last-quarter revenue ($4.2B vs $4.2B, roughly 1.0× IQVIA). Kimberly-Clark runs the higher net margin — 16.2% vs 6.6%, a 9.6% gap on every dollar of revenue. On growth, IQVIA posted the faster year-over-year revenue change (8.4% vs 2.7%). Over the past eight quarters, IQVIA's revenue compounded faster (4.3% CAGR vs -9.0%).

IQVIA Holdings, Inc., headquartered in Durham, North Carolina, is an American company focused on health information technology and clinical research.

Kimberly-Clark Corporation is an American multinational consumer goods and personal care corporation that produces mostly paper-based consumer products. The company manufactures sanitary paper products and surgical & medical instruments. Kimberly-Clark brand name products include Kleenex facial tissue, Kotex feminine hygiene products, Cottonelle, Scott and Andrex toilet paper, Wypall utility wipes, KimWipes scientific cleaning wipes and Huggies disposable diapers and baby wipes.

IQV vs KMB — Head-to-Head

Bigger by revenue
KMB
KMB
1.0× larger
KMB
$4.2B
$4.2B
IQV
Growing faster (revenue YoY)
IQV
IQV
+5.7% gap
IQV
8.4%
2.7%
KMB
Higher net margin
KMB
KMB
9.6% more per $
KMB
16.2%
6.6%
IQV
Faster 2-yr revenue CAGR
IQV
IQV
Annualised
IQV
4.3%
-9.0%
KMB

Income Statement — Q1 FY2026 vs Q1 FY2026

Metric
IQV
IQV
KMB
KMB
Revenue
$4.2B
$4.2B
Net Profit
$275.0M
$675.0M
Gross Margin
36.8%
Operating Margin
12.4%
18.1%
Net Margin
6.6%
16.2%
Revenue YoY
8.4%
2.7%
Net Profit YoY
10.0%
17.3%
EPS (diluted)
$1.61
$2.00

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
IQV
IQV
KMB
KMB
Q1 26
$4.2B
$4.2B
Q4 25
$4.4B
$3.3B
Q3 25
$4.1B
$4.2B
Q2 25
$4.0B
$4.2B
Q1 25
$3.8B
$4.8B
Q4 24
$4.0B
$4.9B
Q3 24
$3.9B
$5.0B
Q2 24
$3.8B
$5.0B
Net Profit
IQV
IQV
KMB
KMB
Q1 26
$275.0M
$675.0M
Q4 25
$514.0M
$499.0M
Q3 25
$331.0M
$446.0M
Q2 25
$266.0M
$509.0M
Q1 25
$249.0M
$567.0M
Q4 24
$437.0M
$447.0M
Q3 24
$285.0M
$907.0M
Q2 24
$363.0M
$544.0M
Gross Margin
IQV
IQV
KMB
KMB
Q1 26
36.8%
Q4 25
37.7%
Q3 25
36.0%
Q2 25
35.0%
Q1 25
35.8%
Q4 24
34.0%
Q3 24
23.5%
36.0%
Q2 24
22.6%
36.0%
Operating Margin
IQV
IQV
KMB
KMB
Q1 26
12.4%
18.1%
Q4 25
14.4%
11.2%
Q3 25
13.5%
15.0%
Q2 25
12.6%
14.2%
Q1 25
13.0%
15.9%
Q4 24
15.8%
11.1%
Q3 24
14.1%
23.3%
Q2 24
13.6%
13.0%
Net Margin
IQV
IQV
KMB
KMB
Q1 26
6.6%
16.2%
Q4 25
11.8%
15.1%
Q3 25
8.1%
10.7%
Q2 25
6.6%
12.2%
Q1 25
6.5%
11.7%
Q4 24
11.0%
9.1%
Q3 24
7.3%
18.3%
Q2 24
9.5%
10.8%
EPS (diluted)
IQV
IQV
KMB
KMB
Q1 26
$1.61
$2.00
Q4 25
$2.97
$1.50
Q3 25
$1.93
$1.34
Q2 25
$1.54
$1.53
Q1 25
$1.40
$1.70
Q4 24
$2.41
$1.34
Q3 24
$1.55
$2.69
Q2 24
$1.97
$1.61

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
IQV
IQV
KMB
KMB
Cash + ST InvestmentsLiquidity on hand
$1.9B
$542.0K
Total DebtLower is stronger
$15.8B
$6.5M
Stockholders' EquityBook value
$6.3B
$1.9M
Total Assets
$29.7B
$17.2M
Debt / EquityLower = less leverage
2.49×
3.38×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
IQV
IQV
KMB
KMB
Q1 26
$1.9B
$542.0K
Q4 25
$2.1B
$688.0M
Q3 25
$2.0B
$617.0M
Q2 25
$2.2B
$634.0M
Q1 25
$1.9B
$563.0M
Q4 24
$1.8B
$1.0B
Q3 24
$1.7B
$1.1B
Q2 24
$1.7B
$1.2B
Total Debt
IQV
IQV
KMB
KMB
Q1 26
$15.8B
$6.5M
Q4 25
$6.5B
Q3 25
$6.5B
Q2 25
$6.5B
Q1 25
$6.5B
Q4 24
$6.9B
Q3 24
$6.9B
Q2 24
$7.2B
Stockholders' Equity
IQV
IQV
KMB
KMB
Q1 26
$6.3B
$1.9M
Q4 25
$6.5B
$1.5B
Q3 25
$6.2B
$1.3B
Q2 25
$5.8B
$1.3B
Q1 25
$6.0B
$1.1B
Q4 24
$6.1B
$840.0M
Q3 24
$7.0B
$1.3B
Q2 24
$6.7B
$1.1B
Total Assets
IQV
IQV
KMB
KMB
Q1 26
$29.7B
$17.2M
Q4 25
$29.9B
$17.1B
Q3 25
$28.7B
$16.9B
Q2 25
$28.6B
$16.8B
Q1 25
$27.3B
$16.3B
Q4 24
$26.9B
$16.5B
Q3 24
$27.2B
$17.2B
Q2 24
$26.4B
$17.3B
Debt / Equity
IQV
IQV
KMB
KMB
Q1 26
2.49×
3.38×
Q4 25
4.31×
Q3 25
4.86×
Q2 25
5.09×
Q1 25
5.89×
Q4 24
8.18×
Q3 24
5.36×
Q2 24
6.30×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
IQV
IQV
KMB
KMB
Operating Cash FlowLast quarter
$618.0M
Free Cash FlowOCF − Capex
$491.0M
FCF MarginFCF / Revenue
11.8%
Capex IntensityCapex / Revenue
Cash ConversionOCF / Net Profit
2.25×
TTM Free Cash FlowTrailing 4 quarters
$2.1B

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
IQV
IQV
KMB
KMB
Q1 26
$618.0M
Q4 25
$735.0M
$972.0M
Q3 25
$908.0M
$708.0M
Q2 25
$443.0M
$770.0M
Q1 25
$568.0M
$327.0M
Q4 24
$885.0M
$817.0M
Q3 24
$721.0M
$958.0M
Q2 24
$588.0M
$1.0B
Free Cash Flow
IQV
IQV
KMB
KMB
Q1 26
$491.0M
Q4 25
$561.0M
$575.0M
Q3 25
$772.0M
$368.0M
Q2 25
$292.0M
$573.0M
Q1 25
$426.0M
$123.0M
Q4 24
$721.0M
$608.0M
Q3 24
$571.0M
$798.0M
Q2 24
$445.0M
$863.0M
FCF Margin
IQV
IQV
KMB
KMB
Q1 26
11.8%
Q4 25
12.9%
17.5%
Q3 25
18.8%
8.9%
Q2 25
7.3%
13.8%
Q1 25
11.1%
2.5%
Q4 24
18.2%
12.3%
Q3 24
14.7%
16.1%
Q2 24
11.7%
17.2%
Capex Intensity
IQV
IQV
KMB
KMB
Q1 26
Q4 25
4.0%
12.1%
Q3 25
3.3%
8.2%
Q2 25
3.8%
4.7%
Q1 25
3.7%
4.2%
Q4 24
4.1%
4.2%
Q3 24
3.9%
3.2%
Q2 24
3.7%
3.1%
Cash Conversion
IQV
IQV
KMB
KMB
Q1 26
2.25×
Q4 25
1.43×
1.95×
Q3 25
2.74×
1.59×
Q2 25
1.67×
1.51×
Q1 25
2.28×
0.58×
Q4 24
2.03×
1.83×
Q3 24
2.53×
1.06×
Q2 24
1.62×
1.88×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

IQV
IQV

Segment breakdown not available.

KMB
KMB

NA$2.7B64%
IPC$1.5B36%

Related Comparisons